Epithalon

Pineal tetrapeptide (Ala-Glu-Asp-Gly) investigated for telomere maintenance, circadian regulation and geroprotective signalling in cell, animal and limited human studies.

Evidence: Preclinical / Small Human Function: Aging & Circadian Biology Class: Pineal tetrapeptide (AEDG)

Explore calculators for this peptide

Use the Peptide Research Tools to experiment with reconstitution, mg/kg ranges and simplified half-life curves for Epithalon. All values are placeholders and must be aligned with your own research protocol.

Open Epithalon in calculators →

Research frame & potential applications

Epithalon (Epitalon, AEDG) is a synthetic analogue of a pineal peptide complex proposed to modulate telomerase activity, circadian rhythms and stress‑response pathways. Cell and animal data suggest telomere maintenance, improved stress resistance and life‑span extension in some models, while small, mostly regional human studies point to potential benefits on age‑related endpoints but require replication under modern trial standards.

Research areas & putative benefits

How Epithalon is being explored in aging, circadian and stress‑biology research.

Modulation of telomerase activity and telomere length in cell cultures and animal tissues, supporting chromosomal stability under replication stress.
Adjustment of circadian rhythms and melatonin secretion profiles, particularly in older organisms with blunted pineal signalling.
Influence on expression of genes associated with DNA repair, antioxidative defence, inflammation and apoptosis in aging tissues.
Exploratory use in elderly cohorts for endpoints such as infection rates, cardiovascular events and functional status, with early but not definitive signals of benefit.

Mechanism stack

Selected pathways that may underlie Epithalon’s reported effects on aging and stress resistance.

Telomeres

Telomerase & telomere length

Epithalon has been shown in vitro to stimulate telomerase activity and support telomere length maintenance in somatic cells exposed to replicative stress, potentially delaying senescence in some cell types.

Gene expression

Epigenetic & transcriptional effects

Transcriptomic work indicates Epithalon can shift expression of genes involved in DNA repair, antioxidant defences, inflammatory cascades and apoptotic signalling, nudging aging tissues toward a more resilient phenotype.

Pineal / circadian

Melatonin & clock regulation

In aging animals and humans, Epithalon has been associated with more youthful melatonin rhythms, improved sleep–wake cycles and normalized circadian hormone patterns, suggesting pineal and clock‑gene interactions.

Stress resistance

Oxidative & metabolic resilience

Animal data suggest increased resistance to oxidative and metabolic stressors after Epithalon, including improved survival under extreme conditions and favourable shifts in markers of lipid peroxidation and antioxidant capacity.

Evidence snapshot

Representative findings from telomere, lifespan and human pilot studies on Epithalon.

Model / context	Observation	Notes
Cell culture models In vitro	Epithalon increased telomerase activity and preserved telomere length in certain human somatic cells, with delayed onset of senescence markers compared with untreated controls.	Supports a mechanistic link between the peptide and telomere maintenance under replicative stress.
Aging rodents Lifespan & aging	Repeated courses of Epithalon in aging rodents have been associated with lifespan extension, reduced incidence of some age‑related pathologies and better maintenance of reproductive and immune functions.	Study designs and conditions vary; independent replication under standardized protocols is limited.
Elderly human cohorts Pilot clinical	Small, often regional studies combining Epithalon or related pineal peptides with other interventions reported lower mortality and improved functional status versus historical controls over multi‑year follow‑up.	Results are hypothesis‑generating and require confirmation in modern randomized trials.
Circadian & endocrine endpoints Physiological	Epithalon has been associated with more youthful melatonin profiles, improved sleep parameters and adjustments in several age‑linked hormonal rhythms.	Fits with its origin as a pineal‑derived peptide and its proposed clock‑modulating actions.

Risk frame & unknowns

Important caveats when interpreting Epithalon’s geroprotective literature.

Important research caveats

Many human studies are small, older, regionally concentrated and combine Epithalon with other interventions, making it hard to isolate its specific contribution.
Long‑term safety data in diverse populations, especially with repeated multi‑year courses, are limited.
Telomerase activation is a double‑edged mechanism; while it may support healthy tissue maintenance, chronic up‑regulation could theoretically interact with oncogenic processes.
Regulatory status and preparation quality vary; off‑label use outside research contexts risks inconsistent dosing and uncontrolled polypharmacy with other aging‑related agents.

This dossier summarizes mechanistic, preclinical and early clinical findings on Epithalon for scientific and educational purposes only. It does not provide medical advice, treatment guidance or dosing recommendations.